FNY Managed Accounts LLC boosted its stake in shares of HealthSouth Corporation (NYSE:HLS) by 6,506.9% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 20,944 shares of the company’s stock after acquiring an additional 20,627 shares during the quarter. HealthSouth accounts for about 1.3% of FNY Managed Accounts LLC’s investment portfolio, making the stock its 24th largest holding. FNY Managed Accounts LLC’s holdings in HealthSouth were worth $970,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently modified their holdings of the company. Advisor Group Inc. boosted its holdings in HealthSouth by 33.8% during the 2nd quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock valued at $149,000 after acquiring an additional 781 shares during the period. Aviva PLC boosted its holdings in HealthSouth by 67.5% during the 2nd quarter. Aviva PLC now owns 43,670 shares of the company’s stock valued at $2,133,000 after acquiring an additional 17,600 shares during the period. Schwab Charles Investment Management Inc. boosted its holdings in HealthSouth by 5.3% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 671,304 shares of the company’s stock valued at $32,492,000 after acquiring an additional 34,035 shares during the period. Prudential Financial Inc. boosted its holdings in HealthSouth by 137.1% during the 2nd quarter. Prudential Financial Inc. now owns 434,679 shares of the company’s stock valued at $21,039,000 after acquiring an additional 251,372 shares during the period. Finally, Great Lakes Advisors LLC boosted its holdings in HealthSouth by 22.1% during the 2nd quarter. Great Lakes Advisors LLC now owns 26,480 shares of the company’s stock valued at $1,282,000 after acquiring an additional 4,796 shares during the period. Institutional investors own 92.43% of the company’s stock.
HLS has been the subject of several analyst reports. ValuEngine cut HealthSouth from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Royal Bank Of Canada restated a “buy” rating on shares of HealthSouth in a report on Wednesday, November 15th. Stephens initiated coverage on HealthSouth in a report on Thursday, August 31st. They set an “overweight” rating and a $53.00 target price for the company. Piper Jaffray Companies restated a “hold” rating and set a $50.00 target price on shares of HealthSouth in a report on Sunday, September 17th. Finally, Zacks Investment Research upgraded HealthSouth from a “sell” rating to a “hold” rating in a report on Wednesday, October 11th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the company’s stock. HealthSouth presently has a consensus rating of “Hold” and a consensus price target of $51.75.
HealthSouth Corporation (NYSE:HLS) opened at $49.16 on Friday. The company has a market capitalization of $4,832.97, a P/E ratio of 17.62, a price-to-earnings-growth ratio of 1.81 and a beta of 0.52. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 1.89. HealthSouth Corporation has a 52-week low of $38.24 and a 52-week high of $50.06.
HealthSouth (NYSE:HLS) last released its quarterly earnings results on Thursday, October 26th. The company reported $0.66 EPS for the quarter, beating analysts’ consensus estimates of $0.65 by $0.01. The business had revenue of $995.60 million during the quarter, compared to analyst estimates of $985.75 million. HealthSouth had a return on equity of 22.81% and a net margin of 6.69%. HealthSouth’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.65 EPS. equities research analysts forecast that HealthSouth Corporation will post 2.72 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, January 16th. Shareholders of record on Tuesday, January 2nd will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 2.03%. The ex-dividend date of this dividend is Friday, December 29th. HealthSouth’s payout ratio is 36.36%.
In other HealthSouth news, Director Yvonne M. Curl purchased 1,000 shares of the stock in a transaction on Wednesday, November 1st. The stock was acquired at an average price of $45.95 per share, with a total value of $45,950.00. Following the transaction, the director now directly owns 64,144 shares of the company’s stock, valued at approximately $2,947,416.80. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.60% of the company’s stock.
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.